Cameron Saffer, MD | |
2020 Capitol St Ne, Salem, OR 97301-0698 | |
(503) 399-2424 | |
(503) 375-7429 |
Full Name | Cameron Saffer |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 2020 Capitol St Ne, Salem, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174940050 | NPI | - | NPPES |
500731816 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD182253 (Oregon) | Secondary |
208D00000X | General Practice | MD182253 (Oregon) | Primary |
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578500492 PECOS PAC ID: 1557260106 Enrollment ID: O20040102000768 |
News Archive
Although Uganda had many achievements to celebrate on the anniversary of its independence on Wednesday, the country must "focus on independence on the individual level," especially among women affected by HIV/AIDS in the country, Milly Nattimba of the Makerere University School of Public Health writes in a New Vision opinion piece.
Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.
Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).
› Verified 8 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366536963 PECOS PAC ID: 6103728753 Enrollment ID: O20040123000371 |
News Archive
Although Uganda had many achievements to celebrate on the anniversary of its independence on Wednesday, the country must "focus on independence on the individual level," especially among women affected by HIV/AIDS in the country, Milly Nattimba of the Makerere University School of Public Health writes in a New Vision opinion piece.
Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.
Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Cameron Saffer, MD Po Box 3060, Portland, OR 97208-3060 Ph: () - | Cameron Saffer, MD 2020 Capitol St Ne, Salem, OR 97301-0698 Ph: (503) 399-2424 |
News Archive
Although Uganda had many achievements to celebrate on the anniversary of its independence on Wednesday, the country must "focus on independence on the individual level," especially among women affected by HIV/AIDS in the country, Milly Nattimba of the Makerere University School of Public Health writes in a New Vision opinion piece.
Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.
Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).
› Verified 8 days ago
Terence H Young, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1875 Liberty St Ne, Salem, OR 97301 Phone: 503-371-1558 Fax: 503-375-3866 | |
Dr. Ivan Dassenko, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 6810 Canyon St Se, Salem, OR 97317 Phone: 503-581-7379 Fax: 503-585-7816 | |
Dr. John Mark Pozar, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 998 Capitol St Ne, Salem, OR 97301 Phone: 503-569-0756 | |
Dr. Michael Brown, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 3777 Commercial St Se, Salem, OR 97302 Phone: 503-588-1234 Fax: 503-371-8662 | |
John M Vargo, D O General Practice Medicare: Not Enrolled in Medicare Practice Location: 4305 Camas Ct Ne, Salem, OR 97305 Phone: 503-378-2302 | |
Stephanie Nicole Reedy, LMT General Practice Medicare: Not Enrolled in Medicare Practice Location: 2515 Liberty St Ne, Salem, OR 97301 Phone: 503-798-1718 |